surmount studies tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide and blood pressure reduction:

Pharmacokinetics, safety, and tolerability of oral semaglutide in healthy subjects and subjects with type 2 diabetes: A randomized, double-blind, placebo-controlled trial

In this trailer episode, we explore: Why GLP-1 weight loss cannot rely on medication alone

While each component has been studied independently across a variety of scientific disciplines, the rationale behind this blend is to provide researchers with a platform for investigating how multiple peptide pathways may operate simultaneously

For this reason, Wegovy should not be used in individuals with ca personal or family history of MTC or with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)